FDA Inspection 906933 — New York Blood Center Inc

New York Blood Center Inc — FEI 3005255747

The FDA completed an inspection of New York Blood Center Inc on December 8, 2014 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 8, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)